SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
901IQLiko
Lv3
330 积分
2022-07-24 加入
最近求助
最近应助
互助留言
Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis
14天前
已完结
Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma
14天前
已完结
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
3个月前
已完结
NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC)
3个月前
已完结
Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use
4个月前
已完结
Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma
6个月前
已完结
Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use
6个月前
已完结
Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab
6个月前
已完结
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib
7个月前
已完结
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib
8个月前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了,么么哒
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论